Periklis Panagopoulos

Periklis Panagopoulos

National and Kapodistrian University of Athens - Athens / Greece
Others
AD Scientific Index ID: 1846019
Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
person_outline Periklis Panagopoulos's MOST POPULAR ARTICLES
1-) Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialE Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ...Nature medicine 27 (10), 1752-1760, 20214862021
2-) Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 …SG Deftereos, G Giannopoulos, DA Vrachatis, GD Siasos, SG Giotaki, ...JAMA network open 3 (6), e2013136-e2013136, 20204792020
3-) Transmission of HIV drug resistance and the predicted effect on current first-line regimens in EuropeLM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...Clinical infectious diseases 62 (5), 655-663, 20161712016
4-) Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trialSMART Study Group*Annals of internal medicine 149 (5), 289-299, 20081682008
5-) An open label trial of anakinra to prevent respiratory failure in COVID-19E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ...Elife 10, e66125, 20211662021